BG104038A - Използване на специфичен антагонист на рецептора 5нт2 за получаване на лекарствени средства за лечение на апнея по време на сън - Google Patents

Използване на специфичен антагонист на рецептора 5нт2 за получаване на лекарствени средства за лечение на апнея по време на сън

Info

Publication number
BG104038A
BG104038A BG104038A BG10403899A BG104038A BG 104038 A BG104038 A BG 104038A BG 104038 A BG104038 A BG 104038A BG 10403899 A BG10403899 A BG 10403899A BG 104038 A BG104038 A BG 104038A
Authority
BG
Bulgaria
Prior art keywords
receptors
disordered breathing
specific antagonist
treating sleep
preparing medicines
Prior art date
Application number
BG104038A
Other languages
English (en)
Inventor
Francoise Cattelin
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of BG104038A publication Critical patent/BG104038A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG104038A 1997-06-26 1999-12-22 Използване на специфичен антагонист на рецептора 5нт2 за получаване на лекарствени средства за лечение на апнея по време на сън BG104038A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707998A FR2765107B1 (fr) 1997-06-26 1997-06-26 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
PCT/FR1998/001100 WO1999000119A1 (fr) 1997-06-26 1998-06-02 Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil

Publications (1)

Publication Number Publication Date
BG104038A true BG104038A (bg) 2001-04-30

Family

ID=9508467

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104038A BG104038A (bg) 1997-06-26 1999-12-22 Използване на специфичен антагонист на рецептора 5нт2 за получаване на лекарствени средства за лечение на апнея по време на сън

Country Status (29)

Country Link
US (1) US6143792A (bg)
EP (1) EP1014960B1 (bg)
JP (1) JP3503953B2 (bg)
KR (1) KR20010014186A (bg)
CN (1) CN1154485C (bg)
AT (1) ATE232094T1 (bg)
AU (1) AU728227B2 (bg)
BG (1) BG104038A (bg)
BR (1) BR9810337A (bg)
CA (1) CA2295119C (bg)
CZ (1) CZ291935B6 (bg)
DE (1) DE69811248T2 (bg)
EE (1) EE9900595A (bg)
ES (1) ES2191942T3 (bg)
FR (1) FR2765107B1 (bg)
HK (1) HK1028351A1 (bg)
HU (1) HU229058B1 (bg)
ID (1) ID23799A (bg)
IL (1) IL133632A (bg)
IS (1) IS2356B (bg)
NO (1) NO325520B1 (bg)
NZ (1) NZ502495A (bg)
PL (1) PL190723B1 (bg)
RU (1) RU2218917C2 (bg)
SK (1) SK283845B6 (bg)
TR (1) TR199903197T2 (bg)
TW (1) TW580386B (bg)
UA (1) UA59397C2 (bg)
WO (1) WO1999000119A1 (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321900C (en) 1998-02-27 2011-07-19 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
FR2787328A1 (fr) * 1998-12-22 2000-06-23 Sanofi Sa Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures
EP1181015A2 (en) * 1999-03-01 2002-02-27 Sepracor Inc. Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
ATE353693T1 (de) * 2002-07-19 2007-03-15 Biovitrum Ab Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
US8512751B2 (en) * 2004-12-20 2013-08-20 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
EP2266554A1 (en) * 2009-05-26 2010-12-29 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
US20120108669A1 (en) * 2008-11-13 2012-05-03 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
EP2186511A1 (en) * 2008-11-13 2010-05-19 Sanofi-Aventis Method of treating sleep disorders using eplivanserin
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
EP2255726A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Spectral profile of SWS enhancing drugs
EP2255807A1 (en) 2009-05-26 2010-12-01 Sanofi-Aventis Method of treating sleep disorders using the combination of eplivanserin and zolpidem
EP2269600A1 (en) * 2009-07-02 2011-01-05 Sanofi-Aventis Treatment of sleep disorders using eplivanserin in COPD patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
EP0449561A3 (en) * 1990-03-29 1992-04-01 Eli Lilly And Company Use of (r)-norfluoxetine in the preparation of a medicament with affinity to 5ht1c receptors
EP0517984A1 (en) * 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines

Also Published As

Publication number Publication date
HUP0002170A3 (en) 2001-12-28
ATE232094T1 (de) 2003-02-15
FR2765107B1 (fr) 2000-03-24
CN1154485C (zh) 2004-06-23
AU8024398A (en) 1999-01-19
NO996442L (no) 2000-02-28
DE69811248D1 (de) 2003-03-13
CZ469599A3 (cs) 2000-04-12
PL190723B1 (pl) 2005-12-30
TR199903197T2 (xx) 2000-05-22
RU2218917C2 (ru) 2003-12-20
US6143792A (en) 2000-11-07
SK283845B6 (sk) 2004-03-02
EE9900595A (et) 2000-08-15
DE69811248T2 (de) 2003-12-04
EP1014960A1 (fr) 2000-07-05
BR9810337A (pt) 2000-09-05
AU728227B2 (en) 2001-01-04
FR2765107A1 (fr) 1998-12-31
ES2191942T3 (es) 2003-09-16
HUP0002170A2 (hu) 2001-11-28
HK1028351A1 (en) 2001-02-16
PL337871A1 (en) 2000-09-11
TW580386B (en) 2004-03-21
NZ502495A (en) 2000-10-27
IS5316A (is) 1999-12-21
NO325520B1 (no) 2008-06-02
NO996442D0 (no) 1999-12-23
JP2001520678A (ja) 2001-10-30
KR20010014186A (ko) 2001-02-26
JP3503953B2 (ja) 2004-03-08
IS2356B (is) 2008-04-15
IL133632A (en) 2003-10-31
ID23799A (id) 2000-05-11
WO1999000119A1 (fr) 1999-01-07
UA59397C2 (uk) 2003-09-15
CA2295119A1 (en) 1999-01-07
SK184599A3 (en) 2000-06-12
IL133632A0 (en) 2001-04-30
CZ291935B6 (cs) 2003-06-18
HU229058B1 (en) 2013-07-29
CN1265586A (zh) 2000-09-06
CA2295119C (en) 2007-02-13
EP1014960B1 (fr) 2003-02-05

Similar Documents

Publication Publication Date Title
EP1080080A4 (en) THERAPEUTIC AGENTS MODULATING THE NEUROKININ RECEPTORS
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
MX9805253A (es) Antagonistas del receptor de vitronectina.
EP0812212A4 (en) COMPOSITIONS FOR ADMINISTRATION OF ANTIGENS
MX9805255A (es) Antagonistas de receptor de vitronectina.
AP2000001785A0 (en) Medicaments
NZ332780A (en) Substituted amines for the treatment of neurological and neuropsychiatric disorders
BG104038A (bg) Използване на специфичен антагонист на рецептора 5нт2 за получаване на лекарствени средства за лечение на апнея по време на сън
MX9704377A (es) Uso de pramipexole como agente neuroprotector.
UA34466C2 (uk) Засіб для несистемної боротьби з паразитуючими комахами
GB9514473D0 (en) Chemical compounds
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
IL112895A (en) Pharmaceutical compositions for the treatment of obsessive-compulsive disorders comprising 5-HT2 antagonists
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
IL136654A0 (en) Hemiasterlin analogs
EP0722748A3 (en) Anesthetic evaporator
SG83723A1 (en) Novel therapeutic agents that modulate 5ht receptors
HUP9802634A3 (en) Use of benzimidazoles for the manufacture of pharmaceutical compositions for the treatment of leukemia
SE9802937D0 (sv) Novel compounds
AU3745795A (en) Use of CCK-B receptor antagonists for the treatment of sleepdisorders
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
ZA200101061B (en) Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein.
AP9200355A0 (en) &#34;Therapeutic agent&#34;
MX9708557A (es) Nuevo uso farmacologico de los antagonistas del receptor aii.
BG106534A (bg) Разтвор за перорално приложение, съдържащ галантамин и подсладител